SEATTLE – If you’re counting those in lasting remission from HIV, Dr. John Mellors of the University of Pittsburgh said here today, there’s been a doubling in their numbers. Now there are two. The dry tone of Mellor’s remarks, and the circumspect wording of Dr. Ravindra Gupta, the physician researcher of University College London, who he […]
Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — To put this in perspective, about 70 million […]
When Dr. Dan Kuritzkes of Harvard Medical School and Brigham and Women’s Hospital presented his team’s findings on two HIV-positive men who remained on antiretroviral therapy while undergoing stem cell transplants, and in whom the levels of HIV DNA had since dropped to undetectable levels, he was careful to emphasize that he was not claiming […]
HIV
Once outbreak was recognized, program put in place reduced number of ongoing transmissions, modeling shows In 2015, when 181 of rural Scott County, Indiana’s 24,000 residents […]
Tuberculosis
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
GENEVA – The countries least responsible for climate change are paying the highest price in health impacts, a delegate from Barbados was the first to note […]